Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | TTR | P02766 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8626918 | 0.88 | ALDH1A1 (0.41) | ALDH1A1MAPT | |
| SCHEMBL16991796 | 0.88 | ALDH1A1 (0.41) | ALDH1A1MAPT | |
| SCHEMBL29522211 | 0.88 | ALDH1A1 (0.41) | ALDH1A1MAPT | |
| SCHEMBL29522160 | 0.88 | ALDH1A1 (0.41) | ALDH1A1MAPT | |
| SCHEMBL2779868 | 0.88 | ALDH1A1 (0.41) | ALDH1A1MAPT | |
| SCHEMBL30197891 | 0.88 | ALDH1A1 (0.41) | ALDH1A1MAPT | |
| Bromide SCHEMBL17217542 | 0.86 | ALDH1A1 (0.40) | ALDH1A1MAPT | |
| Hydrochloric Acid SCHEMBL17216600 | 0.86 | ALDH1A1 (0.40) | ALDH1A1MAPT | |
| Cadaverine Tartrate SCHEMBL16774507 | 0.81 | ALDH1A1 (0.39) | ALDH1A1MAPT | |
| Cadaverine Tartrate SCHEMBL25220108 | 0.81 | ALDH1A1 (0.39) | ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230257408-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-08-17 | — | — | US | disclosed |
| EP-4186882-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-05-31 | — | — | EP | disclosed |
| CN-115836041-A | Process for producing optically active compound | 住友化学株式会社 | 2023-03-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230257408-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE COMPOUND | SIRT1, SIRT3, HCCS | ALDH1A1 323/4885MAPT 3900/4885TTR 4499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.